Get started
CHINA RES.PHARMA.GRP O.N.CHINA RES.PHARMA.GRP O.N.CHINA RES.PHARMA.GRP O.N.

CHINA RES.PHARMA.GRP O.N.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

640 chart


Full chart

640 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.91 B‬ EUR
Dividend yield (indicated)
2.81%
Price to earnings Ratio (TTM)
8.790
Basic EPS (TTM)
0.070 EUR
Net income (FY)
‪451.60 M‬ EUR
Revenue (FY)
‪34.73 B‬ EUR
Shares float
‪1.82 B‬
Beta (1Y)
0.91

Employees


Employees (FY)
‪72.7 K‬
Change (1Y)
−286 −0.39%
Revenue / Employee (1Y)
‪477.67 K‬ EUR
Net income / Employee (1Y)
‪6.21 K‬ EUR

About CHINA RESOURCES PHARMACEUTICAL GR


Sector
Health Technology
Industry
Pharmaceuticals: Major
Headquarters
Hong Kong
Website
crpharm.com
Founded
1938
ISIN
HK0000311099
FIGI
BBG00F3ZDBK4
China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. It operates through the following segments: Manufacturing, Distribution, Retail, and Others. The Manufacturing segment handles the research and development, manufacture, and sale of pharmaceutical and healthcare products. The Distribution segment focuses on the distribution, warehousing, logistics, and pharmaceutical supply chain solutions and services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. The Retail segment deals with the operation of retailing of pharmacy stores. The Others segment comprises of property holding. The company was founded in 1938 and is headquartered in Hong Kong.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

640 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 640.

Frequently Asked Questions


The current price of 640 is 0.585 EUR — it hasn't changed in the past 24 hours. Watch CHINA RES.PHARMA.GRP O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHINA RES.PHARMA.GRP O.N. stocks are traded under the ticker 640.
640 stock has fallen by −6.20% compared to the previous week, the month change is a −6.92% fall, over the last year CHINA RES.PHARMA.GRP O.N. has showed a 0.86% increase.
We've gathered analysts' opinions on CHINA RES.PHARMA.GRP O.N. future price: according to them, 640 price has a max estimate of 1.02 EUR and a min estimate of 0.70 EUR. Watch 640 chart and read a more detailed CHINA RES.PHARMA.GRP O.N. stock forecast: see what analysts think of CHINA RES.PHARMA.GRP O.N. and suggest that you do with its stocks.
640 reached its all-time high on Sep 3, 2018 with the price of 1.400 EUR, and its all-time low was 0.345 EUR and was reached on Dec 20, 2021. View more price dynamics on 640 chart.
See other stocks reaching their highest and lowest prices.
640 stock is 3.42% volatile and has beta coefficient of 0.91. Track CHINA RES.PHARMA.GRP O.N. stock price on the chart and check out the list of the most volatile stocks — is CHINA RES.PHARMA.GRP O.N. there?
Today CHINA RES.PHARMA.GRP O.N. has the market capitalization of ‪3.89 B‬, it has decreased by −6.36% over the last week.
Yes, you can track CHINA RES.PHARMA.GRP O.N. financials in yearly and quarterly reports right on TradingView.
CHINA RES.PHARMA.GRP O.N. is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
640 earnings for the last half-year are 0.03 EUR per share, whereas the estimation was 0.03 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are 0.05 EUR per share. See more details about CHINA RES.PHARMA.GRP O.N. earnings.
CHINA RES.PHARMA.GRP O.N. revenue for the last half-year amounts to ‪15.66 B‬ EUR, despite the estimated figure of ‪15.66 B‬ EUR. In the next half-year revenue is expected to reach ‪16.76 B‬ EUR.
640 net income for the last half-year is ‪100.60 M‬ EUR, while the previous report showed ‪337.39 M‬ EUR of net income which accounts for −70.18% change. Track more CHINA RES.PHARMA.GRP O.N. financial stats to get the full picture.
As of Mar 31, 2025, the company has ‪72.7 K‬ employees. See our rating of the largest employees — is CHINA RES.PHARMA.GRP O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA RES.PHARMA.GRP O.N. EBITDA is ‪2.02 B‬ EUR, and current EBITDA margin is 5.81%. See more stats in CHINA RES.PHARMA.GRP O.N. financial statements.
Like other stocks, 640 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA RES.PHARMA.GRP O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA RES.PHARMA.GRP O.N. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA RES.PHARMA.GRP O.N. stock shows the strong sell signal. See more of CHINA RES.PHARMA.GRP O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.